Cargando…

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus

Detalles Bibliográficos
Autores principales: Ved, Paresh, Shah, Samrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659893/
https://www.ncbi.nlm.nih.gov/pubmed/23776879
http://dx.doi.org/10.4103/2230-8210.107877
_version_ 1782270493560143872
author Ved, Paresh
Shah, Samrat
author_facet Ved, Paresh
Shah, Samrat
author_sort Ved, Paresh
collection PubMed
description
format Online
Article
Text
id pubmed-3659893
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36598932013-06-17 Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus Ved, Paresh Shah, Samrat Indian J Endocrinol Metab Letters to the Editor Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3659893/ /pubmed/23776879 http://dx.doi.org/10.4103/2230-8210.107877 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Ved, Paresh
Shah, Samrat
Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title_full Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title_fullStr Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title_full_unstemmed Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title_short Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
title_sort evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659893/
https://www.ncbi.nlm.nih.gov/pubmed/23776879
http://dx.doi.org/10.4103/2230-8210.107877
work_keys_str_mv AT vedparesh evaluationofvildagliptinandfixeddosecombinationofvildagliptinandmetforminonglycemiccontrolandinsulindoseover3monthsinpatientswithtype2diabetesmellitus
AT shahsamrat evaluationofvildagliptinandfixeddosecombinationofvildagliptinandmetforminonglycemiccontrolandinsulindoseover3monthsinpatientswithtype2diabetesmellitus